Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6

被引:0
作者
Tianzhong Ma
Ning Wang
Zhongjing Su
Ling Chen
Ningxia Zhu
Changhui Ma
Xiancai Chen
Haibin Chen
机构
[1] Medical College of Shantou University,Department of Histology and Embryology
[2] Medical College of Shantou University,Department of Biochemistry and Molecular Biology
来源
Molecular and Cellular Biochemistry | 2011年 / 352卷
关键词
Apoptosis; Proliferation; RNAi; Signal transduction; NF-κB; TRAF6;
D O I
暂无
中图分类号
学科分类号
摘要
Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an activator of the NF-κB transcription factor. NF-κB is involved in a variety of inflammatory, anti-apoptotic, and gene regulatory pathways and was recently found to be over-expressed in esophageal cancer cells. Here we investigated the function of TRAF6 in the esophageal cancer cell line EC109. siRNA targeting TRAF6 was introduced into EC109 cells and TRAF6 mRNA and protein levels were subsequently examined via RT-PCR and western blotting. Rates of apoptosis and cell proliferation were also measured using flow cytometry, ethynyl deoxyuridine (EdU), and CCK-8 (Cell Counting Kit-8) assays. The real-time PCR array was applied to profile the expression of TRAF6 related genes. TRAF6-siRNA reduced TRAF6 mRNA and protein expressions. NF-κB p65 protein expression was decreased in TRAF6-targeting siRNA-transfected cells compared to cells of the negative control. TRAF6-siRNA also significantly inhibited proliferation and enhanced apoptosis of EC109 cells. These studies suggested that TRAF6 was required for NF-κB activation in EC109 cells and it may be a good molecular target for suppressing the survival and proliferation of esophageal cancer cells.
引用
收藏
页码:77 / 85
页数:8
相关论文
共 155 条
[1]  
Trivers KF(2008)Trends in esophageal cancer incidence by histology, United States, 1998–2003 Int J Cancer 123 1422-1428
[2]  
Sabatino SA(2003)Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population Oncol Rep 10 1615-1623
[3]  
Stewart SL(2008)Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells Ann Surg Oncol 15 96-103
[4]  
Xing D(2008)Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, bre, in human esophageal carcinoma cells Biochem Cell Biol 86 302-311
[5]  
Tan W(2007)Nf-kappaB activation in development and progression of cancer Cancer Sci 98 268-274
[6]  
Lin D(2002)Nf-kappaB at the crossroads of life and death Nat Immunol 3 221-227
[7]  
Yoshinaga K(2002)Missing pieces in the NF-kappaB puzzle Cell 109 S81-S96
[8]  
Yamashita K(2009)Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma Nature 462 104-107
[9]  
Mimori K(2004)Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis Cancer 101 2351-2362
[10]  
Tanaka F(2004)Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression Neoplasia 6 390-400